Skip to content

Total Revenue at other companies

Incyte logo
IncyteINCY
$1.27B+20.9%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$0
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$34.37M+55.5%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$25.56M-8.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$56.37M+99.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$17M-39.3%

Segments

By product

See full
Dermatology Therapeutics$1.46M
Contract Research$537K

By segment

See full
Single Reportable$2M

Other financials

Income statement

See full
Gross profit$1.6M+68.7%
Operating income-$22.2M-22.7%
Net income-$19.8M-31.4%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$28.7M-5.6%
Total debt$2.0M-20.1%
Total equity$143.6M-0.3%
Total assets$198.7M+0.3%

Cash flow

See full
Operating cash flow-$18.1M-39.0%
CapEx$13.0K-69.8%
Free cash flow-$18.2M-38.6%

Valuation

See full
Market cap$685.75M+337%
Enterprise value$659.07M+410%
P/S82×+73.1×

Profitability

See full
Gross margin76.3%-9.7pp
Operating margin-961.9%+259pp
Net margin-832.6%+132pp
FCF margin-624.9%

Returns & leverage

See full
Return on equity-48.4%-15.4pp
Debt / equity0.0×
Current ratio-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aclaris Therapeutics's total revenue?
Aclaris Therapeutics (ACRS) reported total revenue of $2M in Q1 2026.
How has Aclaris Therapeutics's total revenue changed year-over-year?
Aclaris Therapeutics's total revenue increased by 37.2% year-over-year, from $1.46M to $2M.
What is the long-term trend for Aclaris Therapeutics's total revenue?
Over 4 years (2021 to 2025), Aclaris Therapeutics's total revenue has grown at a 3.7% compound annual growth rate (CAGR), from $6.76M to $7.83M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.